Use of Novel Oral Anticoagulants Post-cardioversion in Atrial Fibrillation: A Safety Review
S. Mehra, P. Prodduturvar, Constantin B. Marcu, Mihail G. Chelu
Journal of Advances in Medicine and Medical Research · pp. 718–722 · Published 23 Mar 2015
10.9734/BJMMR/2015/16462Abstract
Atrial fibrillation is considered the most common sustained arrhythmia worldwide, especially in geriatric population and is associated with significant morbidity and mortality. Arterial embolization is the most serious complication of atrial fibrillation. Vitamin K antagonists were the only form of oral anticoagulant medication approved for long-term use since 1940s, till the advent of three novel oral anticoagulants- dabigatran, rivaroxaban and apixaban. The new anticoagulants are more convenient to administer than warfarin. Pivotal trials of these drugs showed that they are not only as effective as warfarin, but also cause less intracranial bleeding. There is data emerging regarding the safety of these agents in the context of cardioversion. The purpose of this review is to examine the current published safety data for the use of novel oral anticoagulants around the time of cardioversion.
Cited by 1
Sanjay Mehra · World Journal of Clinical Cases · 2015
Related research
- A Retrospective Observational Case Study to Assess the Safety and Feasibility of Percutaneous Dilatational Tracheostomy Performed by Trainees — shares topic coverage
- Drug-drug Interactions between Warfarin and Antimicrobials: A Systematic Review — shares topic coverage
- Retrospective Analysis of Cancer Cervix at Awal Bros Batam Hospital in 2020-2022 — shares topic coverage
- An Evaluation of the Sub Acute Toxicity and Haemostatic Effects of Leaves Extract of Achyranthes aspera in Mice and Albino Rats — shares topic coverage
- Treatment of ST Elevation Myocardial Infarction from Fibrinolysis to Primary PCI: In Terms of Risks and Benefits — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.